S G Hamda1, J G Tshikuka1,2, D Joel3, V Setlhare1, G Monamodi1, B Mbeha4, B P Tembo4, F Mulenga4, T Agizew1. 1. Faculty of Medicine, Department of Family Medicine and Public Health, University of Botswana, Gaborone, Botswana. 2. Faculty of Health Sciences, National Pedagogic University, Kinshasa, Democratic Republic of Congo. 3. Faculty of Medicine, Department of Paediatrics, University of Botswana, Gaborone, Botswana. 4. Botswana National Tuberculosis Reference Laboratory, Ministry of Health and Wellness, Gaborone, Botswana.
Abstract
SETTING: Seven health facilities with antenatal care (ANC) clinics in two districts near Gaborone, Botswana. OBJECTIVES: To determine 1) the prevalence of tuberculosis (TB) and HIV-TB co-infection in pregnancy, and 2) the sensitivities of symptomatic TB screening and Xpert testing against gold standard culture. DESIGN: This was a cross-sectional study. Pregnant women were randomly enrolled and screened using TB symptoms. HIV status was determined from ANC clinics' client records. Two sputum specimens were collected from all clients and each was tested using Xpert® and culture for Mycobacterium tuberculosis. RESULTS: Of 407 cases, eight had one or more TB symptoms, and all tested negative with Xpert® and culture. Another two (0.5%, 95%CI 0.08-1.96) asymptomatic clients tested positive with both tests. The adjusted TB prevalence was higher than that of the general population (0.6% vs. 0.24%; P < 0.001). The prevalence of TB among HIV-positive and HIV-negative clients was 1/69 (1.45%, 95%CI 0.29-2.61) and 1/336 (0.3%, 95%CI 0.23-0.83), respectively (Fisher's exact test P = 0.312). Xpert® demonstrated a 100% sensitivity and 100% specificity, while symptom screening had 0.0% sensitivity and 98% specificity. CONCLUSIONS: TB prevalence among pregnant women was high and TB symptom screening had limited ability to detect TB. An alternative TB screening algorithm for pregnant women is urgently needed irrespective of TB symptoms.
SETTING: Seven health facilities with antenatal care (ANC) clinics in two districts near Gaborone, Botswana. OBJECTIVES: To determine 1) the prevalence of tuberculosis (TB) and HIV-TB co-infection in pregnancy, and 2) the sensitivities of symptomatic TB screening and Xpert testing against gold standard culture. DESIGN: This was a cross-sectional study. Pregnant women were randomly enrolled and screened using TB symptoms. HIV status was determined from ANC clinics' client records. Two sputum specimens were collected from all clients and each was tested using Xpert® and culture for Mycobacterium tuberculosis. RESULTS: Of 407 cases, eight had one or more TB symptoms, and all tested negative with Xpert® and culture. Another two (0.5%, 95%CI 0.08-1.96) asymptomatic clients tested positive with both tests. The adjusted TB prevalence was higher than that of the general population (0.6% vs. 0.24%; P < 0.001). The prevalence of TB among HIV-positive and HIV-negative clients was 1/69 (1.45%, 95%CI 0.29-2.61) and 1/336 (0.3%, 95%CI 0.23-0.83), respectively (Fisher's exact test P = 0.312). Xpert® demonstrated a 100% sensitivity and 100% specificity, while symptom screening had 0.0% sensitivity and 98% specificity. CONCLUSIONS: TB prevalence among pregnant women was high and TB symptom screening had limited ability to detect TB. An alternative TB screening algorithm for pregnant women is urgently needed irrespective of TB symptoms.
Authors: S Puryear; G Seropola; A Ho-Foster; T Arscott-Mills; L Mazhani; J Firth; D M Goldfarb; R Ncube; G P Bisson; A P Steenhoff Journal: Int J Tuberc Lung Dis Date: 2013-08 Impact factor: 2.373
Authors: Sylvia M LaCourse; Lisa M Cranmer; Daniel Matemo; John Kinuthia; Barbra A Richardson; Grace John-Stewart; David J Horne Journal: J Acquir Immune Defic Syndr Date: 2016-02-01 Impact factor: 3.731
Authors: Andrea Rachow; Alimuddin Zumla; Norbert Heinrich; Gabriel Rojas-Ponce; Bariki Mtafya; Klaus Reither; Elias N Ntinginya; Justin O'Grady; Jim Huggett; Keertan Dheda; Catharina Boehme; Mark Perkins; Elmar Saathoff; Michael Hoelscher Journal: PLoS One Date: 2011-06-29 Impact factor: 3.240
Authors: Matthew Bates; Yusuf Ahmed; Lophina Chilukutu; John Tembo; Busiku Cheelo; Sylvester Sinyangwe; Nathan Kapata; Markus Maeurer; Justin O'Grady; Peter Mwaba; Alimuddin Zumla Journal: Trop Med Int Health Date: 2013-07-03 Impact factor: 2.622
Authors: Zaiyad G Habib; Farouq M Dayyab; Abdallah Sanda; Sirajo H Tambuwal; Mahmood M Dalhat; Hamza Muhammad; Garba Iliyasu; Ibrahim Nashabaru; Abdulrazaq G Habib Journal: Case Rep Infect Dis Date: 2015-08-03